Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CGEM).
- Disclosed ownership: 3.4%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 3.4% ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CGEM) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 3.1% | 1,841,079 | 0 | 1,841,079 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 3.1% | 1,841,079 | 0 | 1,841,079 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 3.1% | 1,841,079 | 0 | 1,841,079 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0.3% | 147,828 | 0 | 147,828 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 0.3% | 147,828 | 0 | 147,828 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 0.3% | 147,828 | 0 | 147,828 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 3.4% | 1,988,907 | 0 | 1,988,907 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |